Pro Medicus (ASX:PME) Expands Cloud Imaging Platform with New Valley Health Contract

Aditi Sarkar

21 August 2026 12:36 AM AEST

Pro Medicus (ASX:PME) Expands Cloud Imaging Platform with New Valley Health Contract

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Pro Medicus (ASX:PME) signed a seven-year A$25 million contract with US healthcare provider Valley Health.
The agreement expands adoption of the Visage 7 cloud-based enterprise imaging platform.
The contract includes imaging workflow, archive migration and cardiology imaging solutions.
Pro Medicus continues to strengthen its position in the North American healthcare IT market.

Pro Medicus Limited (ASX:PME) continues to expand its presence in the global healthcare imaging software market after securing a new long-term contract with Valley Health in the United States. The agreement reinforces Demand for the company’s cloud-based Visage 7 platform and adds another healthcare network to its growing customer base.

The latest contract follows a strong FY2026 performance, where Pro Medicus reported record Revenue growth, higher profitability and significant contract wins across the US healthcare sector. The company continues to focus on replacing legacy imaging systems with scalable cloud-based solutions.

What Just Happened?

On 21 August 2026, Pro Medicus announced that its wholly owned US subsidiary, Visage Imaging, Inc., had signed a seven-year contract valued at A$25 million with Valley Health, a healthcare system based in Winchester, Virginia.

Valley Health operates six hospitals across northern Shenandoah Valley in Virginia and the Eastern Panhandle of West Virginia, with Winchester Medical Center serving as its flagship facility.

The contract covers Pro Medicus’ Visage 7 Viewer, Visage 7 Workflow, Visage 7 Open Archive and Visage 7 Cardiology Imaging solutions.

The platform will be implemented through a cloud-based deployment, with the rollout expected to commence immediately and go live targeted for the first quarter of calendar year 2027.

The agreement also includes migration of Valley Health’s existing PACS archive to Visage 7 Open Archive and integration of medical images with the organisation’s electronic health record system.

Digging Into the Numbers

The Valley Health contract adds to Pro Medicus’ growing portfolio of long-term healthcare technology agreements.

During FY2026, the company reported revenue of $261.7 million, representing growth of 22.9 per cent compared with FY2025. Underlying net profit after tax increased to $144.7 million, while underlying EBIT reached $196.1 million.

The company’s contracted revenue base continued to expand, supported by new and renewed agreements with healthcare providers across North America and Europe.

The FY2026 result included ten new contracts worth a combined $407 million, including major US healthcare agreements. The company also retained all six contracts that came up for renewal during the year.

The latest Valley Health agreement further supports Pro Medicus’ transaction-based revenue model, with potential upside linked to future utilisation of the platform.

Why the Market Is Paying Attention

The Valley Health contract highlights continued demand for Pro Medicus’ cloud-based medical imaging solutions across the US healthcare sector.

The company’s Visage 7 platform is designed to provide a unified imaging environment by combining image viewing, workflow management, archive capabilities and additional specialties such as cardiology imaging.

Healthcare organisations are increasingly seeking to modernise legacy imaging infrastructure, creating opportunities for providers offering scalable cloud-based solutions.

Pro Medicus has positioned its “Full Stack + 1” offering, combining viewer, workflow and archive products with additional imaging specialties, as a key differentiator in the competitive healthcare IT market.

The Valley Health agreement also strengthens the company’s footprint in the Mid-Atlantic US region, where Pro Medicus already serves healthcare customers.

The Bigger Story

Pro Medicus has continued to build its global healthcare informatics platform through the expansion of its Visage 7 technology suite.

The company’s strategy centres on replacing traditional on-premise picture archiving and communication systems (PACS) with cloud-based platforms that can support large healthcare networks.

The US remains a major growth market due to the scale of healthcare systems and ongoing demand for digital transformation. Long-term contracts with hospitals provide Recurring Revenue opportunities as adoption expands.

While Pro Medicus continues to deliver strong financial performance, future growth will depend on maintaining contract momentum, expanding platform adoption and successfully implementing new customer deployments.

What Investors Should Watch Next

Implementation progress of the Valley Health contract ahead of the planned Q1 calendar 2027 go-live.
Further adoption of the Full Stack + 1 Visage 7 platform across healthcare systems.
Additional contract wins across North America and other international markets.
Growth in transaction-based revenue as new customers increase platform usage.
Ability to maintain high margins while scaling global operations.

Conclusion

Pro Medicus (ASX:PME) continues to strengthen its healthcare imaging software platform through the addition of Valley Health as a new US customer. The seven-year agreement expands adoption of Visage 7 and reinforces the company’s strategy of providing cloud-based enterprise imaging solutions.

The latest contract builds on a strong FY2026 performance and highlights ongoing demand for digital healthcare infrastructure. Pro Medicus’ future growth will depend on continued customer adoption, successful implementations and maintaining its competitive position within the global medical imaging market.

FAQs

Q: What is Pro Medicus’ new contract with Valley Health worth?

A:The seven-year contract is valued at A$25 million.

Q: What products are included in the Valley Health agreement?

A:The agreement includes Visage 7 Viewer, Workflow, Open Archive and Cardiology Imaging.

Q: Where is Valley Health located?

A:Valley Health is based in Winchester, Virginia, and operates hospitals across Virginia and West Virginia.

Q: What does Pro Medicus provide?

A:Pro Medicus provides medical imaging software and healthcare informatics solutions.

Q: What is Pro Medicus’ ASX ticker?

A:Pro Medicus trades on the ASX under (ASX:PME).

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.